Publications by authors named "Vincent Hansen"

Claim this Profile
F
Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III studies.
Lee Schwartzberg, Meinolf Karthaus, Giorgia Rossi, Giada Rizzi, Maria E Borroni, Vincent Hansen

Cancer Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Previously Treated Myeloma.
Vincent L Hansen, Morton Coleman, Stephanie Elkins, Jeffrey P Letzer, Moshe Yair Levy

Clin Lymphoma Myeloma Leuk· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron.
Matti Aapro, Meinolf Karthaus, Lee Schwartzberg, Igor Bondarenko, Tomasz Sarosiek, Vincent Hansen

Support Care Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personality traits as a potential predictor of willingness to undergo various orthodontic treatments.
Vincent Hansen, Sean Shih-Yao Liu, Stuart M Schrader, Jeffery A Dean, Kelton T Stewart

Angle Orthod· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of pancreatic and periampullary cancers at a community hospital: successful application of tertiary care treatment standards.
Robert C Moesinger, Jan W Davis, Britani Hill, W Cory Johnston, Carl Gray, Vincent Hansen

Int J Surg Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.
Beth Y Karlan, Amit M Oza, Gary E Richardson, Diane M Provencher, Vincent L Hansen

J Clin Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy.
Wichit Arpornwirat, Istvan Albert, Vincent L Hansen, Jeremey Levin, Rajesh R Bandekar

Cancer· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis